Petix & Botte CO Pfizer Inc Transaction History

Petix & Botte CO

$374 Million
Q3 2024

A detailed history of Petix & Botte CO transactions in Pfizer Inc stock. As of the latest transaction made, Petix & Botte CO holds 10,328 shares of PFE stock, worth $272,246. This represents 0.08% of its overall portfolio holdings.

Number of Shares

10,328

Previous 10,328 -0.0%

Holding current value

$272,246

Previous $288,000 3.47%

% of portfolio

0.08%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $260,885 - $305,708	10,328 New	10,328 $288,000
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $2,508 - $3,258	96 Added 0.93%	10,424 $300,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $186,523 - $215,803	5,164 Added 100.0%	10,328 $378,000
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $240,280 - $284,897	-5,164 Reduced 50.0%	5,164 $271,000
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $236,253 - $292,747	5,164 Added 100.0%	10,328 $535,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $213,376 - $316,295	-5,164 Reduced 50.0%	5,164 $305,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $202,687 - $260,368	5,164 Added 100.0%	10,328 $444,000
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $185,439 - $210,071	-5,164 Reduced 50.0%	5,164 $202,000
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $345,884 - $390,088	10,328 New	10,328 $187,000
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $324,739 - $380,993	-10,228 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $308,067 - $373,731	10,228 New	10,228 $169,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $144,610 - $206,617	-5,350 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $176,122 - $199,876	5,350 New	5,350 $212,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Petix & Botte CO, based on Form 13F filings with the SEC.

News

Stay updated on Petix & Botte CO with notifications on news.

Account